Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter ended June 30, 2017
Filing Date: August 1, 2017
This filing serves as a notification that the Company issued a Press Release on August 1, 2017, announcing its second-quarter financial results. The detailed financial figures and press release are included as Exhibits 99.1 and 99.2, respectively.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references the attached exhibits for these details.
The Company utilizes the following non-GAAP financial measures to supplement IFRS results:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Delivered operating income (Earnings before interest and taxes)
- Free cash flow
Reconciliations between these non-GAAP measures and the most comparable IFRS measures are located in the attached Press Release and Cash Flow Statement.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached Press Release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company states that the inclusion of non-GAAP measures is intended to enhance the user's understanding of current financial performance and future prospects, as well as to ensure consistency with prior reporting periods.
Regulatory Note: The Company explicitly states that these non-GAAP measures should not be used as a substitute for or considered superior to GAAP (IFRS) financial measures.
Liability Disclaimer: The attached exhibits are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2017 revenue and profit figures.
- Examine Exhibit 99.2 for the detailed financial statements and cash flow data.
- Verify the reconciliation of non-GAAP measures (EBITDA, delivered operating income, free cash flow) to IFRS standards as described in the exhibits.
- Confirm the specific year-over-year growth rates and margin changes which are not detailed in this cover letter.